Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NBR2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
PEX6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
C1QTNF3-AMACR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR4755 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IL11RA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
C21orf33 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MFSD4B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HDAC11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NNT-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PDE1A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GGA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SUMF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZMYM4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
YPEL4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAPK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DNAJC30 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on